Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL695927

COc1cc2nccc(Oc3ccc(NC(=O)c4csc(-c5ccc(C(F)(F)F)cc5)n4)cc3F)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MET P08581 15/20 0.59
MST1R Q04912 1/20 0.55
AXL P30530 3/20 0.53
KDR P35968 4/20 0.51
EGFR P00533 1/20 0.51
PDGFRB P09619 1/20 0.51
KIT P10721 1/20 0.51
FLT3 P36888 1/20 0.51
FGFR2 P21802 1/20 0.51
PDGFRA P16234 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL167642 0.97 MET (0.62) METMST1RAXLKDREGFR
Trifluoroacetic Acid SCHEMBL697610 0.93 MET (0.59) METMST1RAXLKDRKIT
SCHEMBL168714 0.89 MET (0.63) METMST1RAXLKDRKIT
Trifluoroacetic Acid SCHEMBL696273 0.87 AXL (0.58) METMST1RAXLKDREGFR
Trifluoroacetic Acid SCHEMBL703131 0.84 MET (0.61) METMST1RKDRFLT3
Trifluoroacetic Acid SCHEMBL698719 0.82 MET (0.70) METKDREGFRPDGFRBKIT
SCHEMBL168401 0.82 AXL (0.61) METMST1RAXLKDREGFR
Trifluoroacetic Acid SCHEMBL705178 0.80 AXL (0.64) METMST1RAXLKDRKIT
Trifluoroacetic Acid SCHEMBL695728 0.80 MET (0.61) METMST1RAXLKDRKIT
SCHEMBL166037 0.80 MET (0.64) METAXLKDREGFRPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609091-B1 PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2014-11-26 EP disclosed
EP-2423208-A1 Pharmaceutically active compounds as Axl inhibitors Lead Discovery Center GmbH (DE) 2012-02-29 EP disclosed